Neopharm Israel is one of the leading pharmaceutical companies in Israel. We provide a comprehensive spectrum of integrated services for international companies seeking to enter or expand their presence in the Israeli Pharmaceuticals, Biotechnology or Healthcare markets. We operate mainly in the fields of rare, and orphan diseases, oncology, hematology, infectious or autoimmune diseases, metabolic diseases, neurology, gastroenterology and dermatology. For more than 75 years we have grown the value of our products and increased our market leadership position in the Israeli market. We are considered the primary partner of choice and a one-stop-shop for multinational biopharma companies, seeking to operate in the Israeli market. Neopharm Israel is part of the privately owned Neopharm Group, One of Israel’s leading providers of innovative integrated solutions across the spectrum of Pharmaceutical, Medical, Consumer Healthcare and Environmental services
View Top Employees from Neopharm IsraelWebsite | http://www.neopharmisrael.com |
Revenue | $35 million |
Employees | 71 (67 on RocketReach) |
Founded | 1941 |
Address | 6, hashiloach st, Petah Tiqwa, Central District 49170, IL |
Industry | Pharmaceutical Manufacturing |
Web Rank | 13 Million |
Looking for a particular Neopharm Israel employee's phone or email?
The Neopharm Israel annual revenue was $35 million in 2023.
Ran Levin is the Vice President Of Business Development of Neopharm Israel.
67 people are employed at Neopharm Israel.
Neopharm Israel is based in Petah Tiqwa, Central District.